Press Releases

CPi Biotech utilises low shear, low pulsation pumps from Watson-Marlow for its bioprocess skids

Peristaltic pumps from Watson-Marlow Fluid Technology Solutions (WMFTS) have been integrated into CPi Biotech’s advanced bioprocess skids CPi Biotech is using a range of peristaltic pumps from WMFTS for transfer, filling and filtration Low shear and low pulsation...

Exploring Unlimited Packaging Opportunities at swop 2024: Bringing together the Emerging Forces of the Industry and Driving the New Development of Packaging

With the expansion of the global consumer market and the development of technological updates, the packaging industry has become a major driver of economic growth. The industry is witnessing increased specialization while focusing on intelligence, environmental protection, and sustainability....

Syntegon launches new SBM Essential Line sterilizers: standardization for shorter delivery times

With the SBM Essential Line, the Syntegon subsidiary Schoeller-Bleckmann Medizintechnik (SBM) launches a new series of its sterilizers, which are based on 50 years of experience. “Thanks to the standardized basis of the SBM Essential Line, pharmaceutical manufacturers benefit...

Elsevier and Iktos partner to deliver an AI-driven synthetic chemistry platform for drug discovery

Elsevier, a global leader in information and data analytics, has signed a multi-year agreement with Iktos, a company specializing in artificial intelligence for new drug discovery. The partnership will strengthen Elsevier's flagship chemistry solution, Reaxys, by combining the company’s...

Charles River and Wheeler Bio Complete Agreement to Accelerate the Journey from Discovery and CMC Development to Manufacturing

Charles River Laboratories International, Inc. announced a strategic agreement with Wheeler Bio, Inc., an antibody contract development and manufacturing organization (CDMO) focused on preclinical and early clinical supply of recombinant proteins, providing clients access to Wheeler’s Portable CMC® (Chemistry,...

Resilience Expands Clinical and Commercial Drug Product Manufacturing Capabilities and Capacities

National Resilience, Inc. (Resilience), Expands Clinical and Commercial Drug Product Manufacturing Capabilities and CapacitiesNational Resilience, Inc. , a technology-focused biomanufacturing company dedicated to broadening access to complex medicines, today announced the expansion of the company’s clinical and commercial drug...

AbbVie and Tentarix Announce Collaboration to Develop Conditionally-Active, Multi-Specific Biologics for Oncology and Immunology

AbbVie Inc. and Tentarix Biotherapeutics today announced a multi-year collaboration focused on the discovery and development of conditionally-active, multi-specific biologic candidates in oncology and immunology. The collaboration will integrate AbbVie's expertise in oncology and immunology with Tentarix's proprietary Tentaclesâ„¢...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read